The Hearing for the Investigation Conducted on CHR Hansen A/S, CHR Hansen Gıda San. ve Tic. AŞ, Novo Holdings A/S, Novo Nordisk A/S, Novo Nordisk Sağlık Ürünleri Tic. Ltd. Şti., Novonesis A/S, Novozymes Berlin GmbH., Novozymes Enzim Dış Ticaret Ltd. Şti., Novozymes France S.A.S., Novozymes North America Novo Nordisk A/S, Novozymes Switzerland AG and Synergia Life Sciences Pvt. Ltd. to Be Held on October 21, 2025. (30.9.2025)
The investigation conducted in order to determine if the undertakings operating in the market for industrial enzymes violated Article 6 of the Act no 4054 on the Protection of Competition has reached the hearing stage. The hearing concerned will be held on October 21, 2025, at 10.30.
Complainants and third parties who wish to attend the meeting in accordance with the "Communiqué on Hearings Held before the Competition Board" to make a statement should apply to the Competition Authority with a petition containing the information and documents which establish their interest in the subject matter of the meeting until the end of the business hours on October 14, 2025.
Those who wish to sit in on the hearing can follow the meeting online. To that end, the participation form must be filled in accordance with the directions on the Competition Authority website, half an hour before the time of the meeting at the latest.
Respectfully submitted for the information of the public.